This article is general information drawn from official sources. It is not legal advice. The law changes, and state and territory rules differ. For any specific situation, get independent legal advice.
In plain English
Peptides are short chains of amino acids (the building blocks of proteins). In Australia, peptide products are regulated as therapeutic goods, which means the Therapeutic Goods Administration (TGA) oversees how they are imported, made, sold and advertised [1, 4].
A few peptide medicines, such as insulin products, have been assessed and approved [1]. Most peptides promoted online have not. They are not on the Australian Register of Therapeutic Goods (ARTG), the official list of approved products, so the TGA has not checked their safety, quality or effectiveness [8, 9].
Separately, a national rulebook called the Poisons Standard sorts substances into “Schedules”. Many peptides promoted online, including BPC-157, TB-500 and CJC-1295, are in Schedule 4 (prescription-only). Some are also in Appendix D, clause 5, which makes possessing them without authority illegal [3].
Writing “research use only” on a label does not change any of this, according to the TGA [1].
The short version
- Peptide products are regulated as therapeutic goods [1, 4].
- Most peptides sold online are not approved [1].
- Many are prescription-only, and some carry possession controls [3].
- A “research use only” label does not make supply lawful [1].
The short answer
| Question | What the official sources say |
|---|---|
| Are peptide products regulated? | Yes. Under the Therapeutic Goods Act 1989, peptide products are regulated as therapeutic goods [1, 4]. |
| Are most promoted peptides approved? | No. Unapproved peptide products are those not included on the ARTG. The TGA names BPC-157, GHK-Cu, TB-500 and CJC-1295 among its examples [1]. |
| Are some peptides prescription-only? | Yes. Many are listed in Schedule 4 (Prescription Only Medicines) of the Poisons Standard [3]. |
| Is possession controlled? | For some, yes. Appendix D, clause 5 of the Poisons Standard lists poisons that must not be possessed without authority, including several peptides [3]. |
| Does “research use only” change this? | No. The TGA states that such disclaimers alone do not change a product’s regulatory status, permit importation, or remove advertising or supply obligations [1]. |
| Can unapproved peptides be advertised? | Advertising unapproved therapeutic goods to Australian consumers is generally unlawful [5]. |
Which laws apply to peptides?
Several layers of law apply at once.
| Law or instrument | Who administers it | What it does |
|---|---|---|
| Therapeutic Goods Act 1989 | Commonwealth (TGA) | Regulates therapeutic goods, including the ARTG and the import, manufacture, supply and advertising of therapeutic goods [4, 5] |
| Poisons Standard (SUSMP) | Commonwealth decisions, implemented by states and territories | Classifies substances into Schedules that set the level of control on their availability [3, 6] |
| Therapeutic Goods Advertising Code | Commonwealth (TGA) | Sets requirements for advertising therapeutic goods to the public [7] |
| State and territory poisons laws | Each state and territory | Put the Schedules into effect and may add controls on sale, supply and possession [1, 3] |
What does “not on the ARTG” mean?
The ARTG is the register of therapeutic goods that can be supplied in Australia [8]. Goods that are not on it are “unapproved”. The TGA has not assessed them for safety, quality or effectiveness [9].
Some peptide medicines are on the ARTG. The TGA gives insulin products as an example [1]. But most peptides promoted online are not. The TGA states that advertising unapproved therapeutic goods to Australian consumers is generally unlawful [5].
Lawful access to unapproved goods is limited to defined pathways, such as the Special Access Scheme, the Authorised Prescriber Scheme and the clinical trial schemes, each with its own conditions [9]. See Research Peptides vs Approved Peptide Medicines.
How does the Poisons Standard classify peptides?
The Poisons Standard (also called the SUSMP) groups substances into Schedules. Each Schedule reflects how tightly availability should be controlled [3, 6]. The current edition is the Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 [3].
| Schedule | Title | General description (summarised from the instrument) |
|---|---|---|
| 2 | Pharmacy medicines | Available from a pharmacy [3] |
| 3 | Pharmacist only medicines | Available from a pharmacist without a prescription [3] |
| 4 | Prescription only medicines | Use or supply should be by or on the order of a person permitted by state or territory law to prescribe, and available from a pharmacist on prescription [3] |
| 8 | Controlled drugs | Restricted manufacture, supply, distribution, possession and use [3] |
| 9 | Prohibited substances | Prohibited except for approved medical or scientific research, analysis, teaching or training [3] |
| 10 | Prohibited for specified purposes | Supply and use prohibited for the listed purposes [3] |
Two points from the instrument itself are easy to miss [3]:
- Scheduling is not approval. Inclusion in a Schedule does not mean a substance is available, approved or effective, and it does not remove the need for registration.
- Derivatives and salts are usually caught. A Schedule entry generally includes preparations, salts and derivatives of the poison unless the entry says otherwise.
Peptides with extra possession controls (Appendix D, clause 5)
Appendix D, clause 5 lists “poisons for which possession without authority is illegal”, for example possession other than in accordance with a legal prescription. In the October 2026 instrument, peptide and protein entries include [3]:
| Entry in Appendix D, clause 5 (selected) |
|---|
| BPC-157 |
| CJC-1295 |
| Growth hormone releasing hormones (GHRHs) |
| Growth hormone releasing peptides (GHRPs), including GHRP-6 and pralmorelin (GHRP-2) |
| Growth hormone secretagogues |
| Hexarelin |
| Insulin-like growth factors |
| Ipamorelin |
| TB-500 and thymosin beta 4 |
| Fibroblast growth factors, follistatin, erythropoietins and somatropin (growth hormone) |
This is a selection. The full table also lists non-peptide substances. Check the current instrument for the complete, authoritative wording [3].
Not every peptide is scheduled. Scheduling is substance by substance. If a peptide is not named in the Poisons Standard, that does not make it an approved therapeutic good. It is still unapproved if it is not on the ARTG [1, 3]. We do not state a schedule for any peptide unless we can confirm it in the current instrument.
Does “research use only” make supply lawful?
No, according to the TGA. In its April 2026 guidance on peptides, the TGA states that “research use only” disclaimers alone do not [1]:
- change a product’s regulatory status
- permit importation
- remove advertising or supply obligations.
The Poisons Standard contains a related point. Poisons packed and sold solely for industrial, manufacturing, laboratory or dispensary use are exempt from the instrument’s labelling requirements, but that exemption does not extend to controls on supply [3].
The TGA also notes that state and territory laws may impose additional controls on the sale, supply and possession of unapproved peptide products [1].
What about importing peptides?
Importing therapeutic goods is regulated by the TGA, and the TGA states that a “research use only” label does not permit importation [1]. Lawful access to unapproved therapeutic goods is limited to defined pathways, each with its own conditions [9].
For peptides specifically, the TGA states that imported products identified only by codes, or that do not clearly state the active ingredient and strength, cannot be assessed and will not be considered for release [1]. Importing a prescription-only peptide without the required authority has led to infringement notices [11].
What are the advertising rules?
The Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021 sets requirements for advertising therapeutic goods to the public [7, 12]. The TGA’s position on peptides is [1, 5]:
- advertising prescription-only medicines to the public is prohibited, unless authorised or required by a government authority
- it is unlawful to advertise some therapeutic goods that are not on the ARTG to the public, however or wherever they are promoted
- influencers, affiliates, online sellers and anyone else promoting unapproved peptide products may be held accountable for unlawful advertising.
How is the TGA enforcing the rules?
Published TGA notices show increasing enforcement activity:
- June 2026: the TGA added unapproved peptide products to its compliance priorities, citing increased detection of unlawful importation, supply and advertising [2].
- July 2026: the TGA warned promoters and suppliers that they may face warning letters, infringement notices, product seizures and forfeiture, civil penalties and, in serious cases, criminal prosecution. It noted that “manufacture” includes steps such as applying a label to a blank vial [5].
- August 2026: with NSW Police, the TGA seized more than $120,000 of peptide and anabolic steroid products allegedly linked to a social media influencer [10].
- April 2024: the TGA issued a $3,756 infringement notice to a Victorian individual for allegedly importing a prescription-only peptide without approval or authority [11].
The TGA states that penalties for breaches of the Act include civil penalties of up to $1.82 million per breach for individuals or $18.2 million per breach for corporations, and criminal penalties of up to 7 years’ imprisonment [10]. The TGA keeps a public list of infringement notices it has issued [13].
What this means in Australia
- ARTG. If a peptide product is not on the ARTG, it is an unapproved therapeutic good. The TGA has not assessed it for safety, quality or effectiveness [8, 9]. The TGA names BPC-157, GHK-Cu, TB-500 and CJC-1295 among its examples of unapproved peptide products [1].
- Poisons Standard. The current edition is the October 2026 instrument [3]. Schedule 4 means prescription-only. Appendix D, clause 5 means possessing the substance without authority is illegal. BPC-157, TB-500, thymosin beta-4, CJC-1295, ipamorelin, GHRP-6 and pralmorelin (GHRP-2) are each named in both [3]. A peptide that is not named is not thereby approved or unregulated; it is still unapproved if it is not on the ARTG [1, 3].
- TGA position. In April 2026 the TGA stated that “research use only” disclaimers do not make supply lawful. They do not change a product’s regulatory status, permit importation, or remove advertising or supply obligations [1]. Advertising unapproved therapeutic goods to Australian consumers is generally unlawful, and this includes websites [5]. In June 2026 the TGA added unapproved peptide products to its compliance priorities [2].
- Sport. Anti-doping rules are a separate system.
This is general information, not legal advice. Laws change; check the current Poisons Standard and TGA guidance.
Frequently asked questions
Are peptides legal in Australia?
Some peptide medicines are approved and on the ARTG. Most peptides promoted online are unapproved, many are Schedule 4 prescription-only medicines, and some carry extra possession controls under Appendix D [1, 3]. The legal position depends on the specific substance and activity.
Is BPC-157 legal in Australia?
BPC-157 is not on the ARTG. It is listed in Schedule 4 of the Poisons Standard and in Appendix D, clause 5, which covers poisons that must not be possessed without authority [1, 3].
Are all peptides prescription-only?
No. Scheduling is substance-specific. A peptide that is not scheduled is still unapproved if it is not on the ARTG [1, 3].
Does a “research use only” label make peptides legal to sell?
The TGA states that it does not. Such disclaimers alone do not change regulatory status, permit importation, or remove advertising or supply obligations [1].
Can peptides be advertised in Australia?
Advertising prescription-only medicines to the public is prohibited unless authorised, and advertising unapproved therapeutic goods to consumers is generally unlawful [1, 5].
Are peptides banned in sport as well?
Many are. That is a separate set of rules under the World Anti-Doping Code.
References
- Therapeutic Goods Administration. Understanding your responsibilities when importing, compounding and supplying unapproved peptide products. Safety advisory, 13 April 2026. tga.gov.au. Accessed 11 October 2026.
- Therapeutic Goods Administration. TGA strengthens compliance focus on unapproved peptide products as part of evolving risk response. Media release, 10 June 2026. tga.gov.au. Accessed 11 October 2026.
- Australian Government. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327), including Reader’s guide and Appendix D. Federal Register of Legislation. legislation.gov.au/F2026L01327/latest/text. Accessed 11 October 2026.
- Australian Government. Therapeutic Goods Act 1989. Federal Register of Legislation. legislation.gov.au/C2004A03952/latest/text. Accessed 11 October 2026.
- Therapeutic Goods Administration. Unapproved peptide product promoters and suppliers are put on notice. Media release, 20 July 2026. tga.gov.au. Accessed 11 October 2026.
- Therapeutic Goods Administration. The Poisons Standard (the SUSMP). tga.gov.au. Accessed 11 October 2026.
- Australian Government. Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021 (F2021L01661). Federal Register of Legislation. legislation.gov.au/F2021L01661/latest/text. Accessed 11 October 2026.
- Therapeutic Goods Administration. Australian Register of Therapeutic Goods (ARTG). tga.gov.au/resources/artg. Accessed 11 October 2026.
- Therapeutic Goods Administration. Unapproved therapeutic goods. tga.gov.au/products/unapproved-therapeutic-goods. Accessed 11 October 2026.
- Therapeutic Goods Administration. TGA flexes its muscle against illegal peptides and steroids. Media release, 17 August 2026. tga.gov.au. Accessed 11 October 2026.
- Therapeutic Goods Administration. Victorian fined for allegedly importing unapproved peptide. Media release, 29 April 2024. tga.gov.au. Accessed 11 October 2026.
- Therapeutic Goods Administration. Applying the Advertising Code. tga.gov.au. Accessed 11 October 2026.
- Therapeutic Goods Administration. Infringement notices. tga.gov.au. Accessed 11 October 2026.
Important information and disclaimer
General information only. This article is published for general educational and informational purposes. It summarises published scientific literature and public regulatory information as at the “last reviewed” date shown above. It is not medical, health, pharmaceutical, veterinary or legal advice, and it must not be relied on as a substitute for advice from a qualified professional about your circumstances.
Not for human or animal use. Nothing in this article recommends, endorses or describes the use of any substance in humans or animals. Findings from cell, animal or early human studies cannot be assumed to apply to people. The compounds discussed have not been evaluated by the Therapeutic Goods Administration (TGA) for safety, quality or efficacy unless the article expressly states otherwise. Any research materials offered by Iconic Peptides are supplied solely for in vitro and laboratory research.
No therapeutic claims. Iconic Peptides makes no claim that any product treats, cures, prevents, alleviates or diagnoses any disease, condition or symptom. References to published studies, clinical trials or medicines approved by regulators are factual descriptions of the scientific and regulatory record. They are not representations about any product we supply.
Regulatory status. Many peptides are scheduled substances under the Poisons Standard. Some are prescription-only (Schedule 4), and some may not be possessed without authority (Appendix D). The TGA has stated that a “research use only” label does not make supply lawful, change a product’s regulatory status, or remove advertising or supply obligations. State and territory laws may also apply. You are responsible for knowing and complying with all laws that apply to you. Regulatory information in this article may change after the review date.
Accuracy and third-party sources. We take care to cite and verify every source, but we do not warrant that this article is complete, current or error-free. Citing a study or organisation does not mean that its authors or that organisation endorse Iconic Peptides.
Limitation of liability. To the maximum extent permitted by law, Iconic Peptides, its owners, employees and contributors exclude all liability for any loss, damage, injury or expense, whether direct, indirect or consequential, arising from use of or reliance on this article or any misuse of any product. Nothing in this disclaimer excludes, restricts or modifies any right or remedy under the Australian Consumer Law that cannot lawfully be excluded.
Age restriction. This website is intended for adults aged 18 and over.
